Patents by Inventor Christiane Garbay

Christiane Garbay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-CARBAMOYLPUTRESCINE TO ENHANCE MUSCLE PROTEIN SYNTHESIS
    Publication number: 20170340587
    Abstract: The present invention relates to the field of food supplement and medicament supporting muscle metabolism, more precisely muscle protein synthesis. In particular, the invention relates to a composition comprising N-carbamoylputrescine (NCP). The invention further relates to the non-therapeutic use of N-carbamoylputrescine (NCP) to enhance muscle protein synthesis in a subject. Moreover, the invention also relates to N-carbamoylputrescine for its use as a medicament.
    Type: Application
    Filed: November 23, 2016
    Publication date: November 30, 2017
    Inventors: Jean-Pascal DE BANDT, Luc CYNOBER, David RAMANI, Christiane GARBAY
  • N-carbamoylputrescine to enhance muscle protein synthesis
    Patent number: 9533946
    Abstract: The present invention relates to the field of food supplement and medicament supporting muscle metabolism, more precisely muscle protein synthesis. In particular, the invention relates to a composition comprising N-carbamoylputrescine (NCP). The invention further relates to the non-therapeutic use of N-carbamoylputrescine (NCP) to enhance muscle protein synthesis in a subject. Moreover, the invention also relates to N-carbamoylputrescine for its use as a medicament.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: January 3, 2017
    Assignee: CITRAGE
    Inventors: Jean-Pascal De Bandt, Luc Cynober, David Ramani, Christiane Garbay
  • Method for manufacturing optically pure coumaryl amino acids and the novel coumaryl aminoacids thus obtained
    Publication number: 20070161807
    Abstract: The present invention relates to the field of the synthesis of optically pure amino acid derivatives, mainly for the purpose of manufacturing optically active polypeptides that are useful as labelled detection tools.
    Type: Application
    Filed: January 28, 2005
    Publication date: July 12, 2007
    Applicant: INSERM (INSTITUT NATIONAL DE LA SANT'E ET DE LA RECHERCHE MEDICALE
    Inventors: Christiane Garbay, Laurent Bischoff, Marie-Priscille Brun
  • Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same
    Publication number: 20020055463
    Abstract: The invention concerns a compound corresponding to general formula (1) wherein, in particular, R2 represents a phenylmethyl or naphthylmethyl or cyclohexylmethyl radical, 2- and 3-pryidinylmethyl, substituted on the cycle in meta or para position by an acid group or an alkyl radical of the type (CH2)n (with n=3 or 4) substituted in terminal position by an acid group; and R3 represents a hydrogen group or a linear or branched C1-C4 alkyl or alkylcycloalkyl with a C3-C6 cycloalkyl. The invention also concerns the use of a compound of general formula (I) for preparing a pharmaceutical composition for treating diseases related to proliferative processes, cancers and/or metastases.
    Type: Application
    Filed: October 16, 2001
    Publication date: May 9, 2002
    Inventors: Christiane Garbay, Wang-Qing Liu, Michel Vidal, Bernard P. Roques